SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-013510
Filing Date
2019-11-06
Accepted
2019-11-06 16:33:44
Documents
62
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgmo-20190930x10q.htm   iXBRL 10-Q 1826924
2 EXHIBIT 10.1 sgmo-20190930xex101.htm EX-10.1 568102
3 EXHIBIT 31.1 sgmo-20190930xex311.htm EX-31.1 13269
4 EXHIBIT 31.2 sgmo-20190930xex312.htm EX-31.2 13314
5 EXHIBIT 32.1 sgmo-20190930xex321.htm EX-32.1 10279
  Complete submission text file 0001628280-19-013510.txt   8243572

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20190930.xsd EX-101.SCH 49656
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20190930_cal.xml EX-101.CAL 90400
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20190930_def.xml EX-101.DEF 237835
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20190930_lab.xml EX-101.LAB 623417
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20190930_pre.xml EX-101.PRE 370956
37 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20190930x10q_htm.xml XML 1350172
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 191196818
SIC: 2836 Biological Products, (No Diagnostic Substances)